Retatrutide

Retatrutide

£100.00
£100.00
Sale Sold out
Tax included.

Retatrutide 60mg is a triple agonist peptide that activates GLP-1, GIP, and glucagon receptors. It enhances insulin secretion, increases energy expenditure, and reduces appetite, resulting in significant improvements in weight loss and metabolic regulation. Retatrutide is peptide analog supplied in a 60mg lyophilized powder form per vial. This compound is designed exclusively for laboratory and scientific research and is not approved for human or veterinary use.

Manufactured under stringent quality control standards, this Retatrutide formulation ensures high purity and stability, making it suitable for precision-based experimental applications.

Product Specifications

Quantity: 60mg per vial

Form: Lyophilized powder

Purity: ≥98%

Storage: Store at 2–8°C

Handling: For use by qualified research professionals only

Important Notice

This product is intended solely for research purposes. It is not for human consumption or for use in therapeutic, diagnostic, or clinical procedures.

Legal & Safety Information

Precision Peptides supplies items strictly for laboratory and scientific research purposes only. As part of our commitment to supporting the research community, we ensure all products are manufactured and handled in accordance with high quality standards and applicable regulatory requirements. All peptides and products sold by Precision Peptides are not intended for human consumption, medical use, or clinical application.

Important Notice

This product is for research purposes only. Not intended for human consumption, diagnostic procedures, or therapeutic use.

View full details